7+ mon, 2+ day ago  (307+ words) The medical terminology likely needs modernization, due to patients" misinterpreting Sj'gren "syndrome" as an undefined set of bothersome symptoms. In reality, "it is a disease with serious morbidity and, for some, increased mortality." Also, the label "secondary" Sj'gren does not…...

1+ mon, 3+ day ago  (250+ words) Cognitive behavioral therapy (CBT) may improve sleep disturbances among individuals with acquired brain injury, according to study findings published in Sleep Medicine. Sleep disturbances are common among individuals with acquired brain injury " including those recovering from traumatic brain injury or…...

4+ mon, 1+ week ago  (388+ words) The Food and Drug Administration has approved Itvisma" (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy in adult and pediatric patients aged 2 years and older with confirmed mutation in the SMN1 gene. Spinal muscular atrophy (SMA) is a genetic neuromuscular…...

1+ week, 16+ hour ago  (278+ words) The Food and Drug Administration (FDA) has approved a high dose regimen for Spinraza" (nusinersen) for the treatment of spinal muscular atrophy (SMA). The approval of the high dose regimen was supported by data from the phase 2/3 DEVOTE trial (Clinical…...

8+ mon, 5+ day ago  (248+ words) The Food and Drug Administration (FDA) has approved Ajovy" (fremanezumab-vfrm) for the preventive treatment of episodic migraine in pediatric patients aged 6 to 17 years weighing at least 45 kg." Fremanezumab is a calcitonin gene-related peptide antagonist. It was originally approved in 2018 as…...

6+ mon, 2+ week ago  (317+ words) Patients with gout in the United States are at greater risk for chronic opioid exposure than matched peers without gout, according to results of a large national cohort study published in Arthritis Care & Research. To investigate this risk, researchers conducted…...

4+ mon, 1+ week ago  (214+ words) Mortality rates are significantly lower among patients with medication-resistant epilepsy treated with cenobamate compared with those receiving other antiseizure medications (ASMs), according to study results presented at the American Epilepsy Society (AES) Annual Meeting 2025, held from December 5 to 9 in Atlanta,…...

4+ mon, 3+ week ago  (425+ words) In one systematic review, the mean age of children presenting with extramedullary symptoms of ALL was 7. 34. 6 years. Given that the peak incidence of ALL is observed among children less than 5 years of age, initial presentation of extramedullary symptoms may contribute…...

11+ mon, 1+ week ago  (385+ words) Patients with drug-resistant epilepsy (DRE) treated with cenobamate experience meaningful reductions in seizure frequency and high rates of treatment retention, according to the findings of a study published in Epilepsia Open. Individuals with DRE face limited options after multiple antiseizure…...

7+ mon, 2+ week ago  (318+ words) Most participants with newly diagnosed focal episodes achieve seizure freedom; 27% become seizure-free with the first ASM. Health Day News " Many people with newly diagnosed focal episodes take more. .. Health Day News " Many people with newly diagnosed focal episodes take more…...